| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/128.1.15 |
| P698 | PubMed publication ID | 4198024 |
| P50 | author | Scott B Halstead | Q60059357 |
| P2093 | author name string | Casals J | |
| Shotwell H | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | laboratory | Q483242 |
| pathogenesis | Q372016 | ||
| Dengue virus | Q476209 | ||
| P304 | page(s) | 15-22 | |
| P577 | publication date | 1973-07-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection | |
| P478 | volume | 128 |
| Q43046555 | A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease? |
| Q40329672 | A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness |
| Q40778595 | A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination |
| Q40612834 | Alteration of virus entry mode: a neutralisation mechanism for Dengue-2 virus |
| Q27473379 | American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells |
| Q35272502 | An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques |
| Q38647063 | Animal models for dengue vaccine development and testing. |
| Q37987131 | Animal models of dengue virus infection |
| Q51803005 | Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. |
| Q39678175 | Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus |
| Q28185515 | Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications |
| Q40884212 | Antibody-enhanced dengue virus infection in primate leukocytes |
| Q26825708 | Can non-human primates serve as models for investigating dengue disease pathogenesis? |
| Q27470062 | Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections |
| Q27477638 | Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections |
| Q27473185 | Contact sensitivity and tolerance induction to DNFB in experimental dengue virus infection |
| Q40047603 | Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections |
| Q35830864 | Current advances in dengue diagnosis |
| Q91271250 | Dengue |
| Q26827164 | Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment |
| Q40614639 | Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever |
| Q24550739 | Dengue and dengue hemorrhagic fever |
| Q38614539 | Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past. |
| Q45324373 | Dengue fatal cases present virus-specific HMGB1 response in peripheral organs. |
| Q27486141 | Dengue haemorrhagic fever--a public health problem and a field for research |
| Q27486143 | Dengue hémorragique—problème de santé publique et domaine de recherche |
| Q92397008 | Dengue infection and advances in dengue vaccines for children |
| Q40198181 | Dengue virus and host antibody: a dangerous balancing act. |
| Q40532464 | Dengue virus serotyping based on envelope and membrane and nonstructural protein NS1 serotype-specific capture immunoglobulin M enzyme-linked immunosorbent assays |
| Q27485050 | Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody |
| Q35294150 | Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera |
| Q33898170 | Dengue-2 vaccine: viremia and immune responses in rhesus monkeys |
| Q38201151 | Developing a dengue vaccine: progress and future challenges |
| Q34259867 | Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells |
| Q61053638 | Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned |
| Q35031833 | Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques |
| Q40527785 | Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine |
| Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
| Q55519030 | Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. |
| Q35140466 | Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus |
| Q37698942 | Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle |
| Q36730637 | Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains |
| Q41929035 | Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response |
| Q38381598 | Homotypic Dengue Virus Reinfections in Nicaraguan Children |
| Q47551925 | Immune Response to Dengue and Zika |
| Q35613349 | Immunology and immunopathogenesis of dengue disease |
| Q38157106 | Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques |
| Q40124689 | Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine |
| Q34084857 | Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures |
| Q40528042 | Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity |
| Q28236244 | Manipulation of cell surface macromolecules by flaviviruses |
| Q33610555 | Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q27480391 | Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge |
| Q24684689 | Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention |
| Q37213365 | Mouse models of dengue virus infection and disease |
| Q27010151 | Mouse models to study dengue virus immunology and pathogenesis |
| Q29618172 | Neutralization and antibody-dependent enhancement of dengue viruses |
| Q26766198 | Pathogenesis of Dengue: Dawn of a New Era |
| Q27860978 | Pathogenesis of dengue: challenges to molecular biology |
| Q42986334 | Preparation of Japanese encephalitis virus nonstructural protein NS1 obtained from culture fluid of JEV-infected Vero cells |
| Q27485489 | Primary and Secondary Infections of Macaca fascicularis Monkeys with Asian and American Genotypes of Dengue Virus 2 |
| Q66678770 | Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques |
| Q40037808 | Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques |
| Q40626033 | Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia |
| Q92859173 | Recent advances in understanding dengue |
| Q27485981 | Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones |
| Q34058747 | Report of an NIAID workshop on dengue animal models |
| Q91728039 | Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques |
| Q40781302 | Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). |
| Q37372592 | Serotype-specific host responses in rhesus macaques after primary dengue challenge |
| Q33709817 | Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control |
| Q40863361 | Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys |
| Q40728679 | Suppression of intrinsic B-cell function in Dengue-infected mice |
| Q33952146 | The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease |
| Q40172034 | The haemostatic defect in viral haemorrhagic fevers |
| Q34903764 | The history and evolution of human dengue emergence |
| Q37987124 | The human antibody response to dengue virus infection |
| Q98386109 | The role of IgG Fc receptors in antibody-dependent enhancement |
| Q27480996 | Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 |
| Q38540058 | Trials and tribulations on the path to developing a dengue vaccine |
| Q65054977 | Using Macaques to Address Critical Questions in Zika Virus Research. |
| Q34238916 | Utility, limitations, and future of non-human primates for dengue research and vaccine development |
| Q27486148 | Viraemia in patients with naturally acquired dengue infection |
| Q27478050 | Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever |
| Q39011713 | Wild dengue virus types 1, 2 and 3 viremia in rhesus monkeys |
| Q33850577 | Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus |
| Q24570060 | “Original Antigenic Sin” Phenomenon in Experimental Flavivirus Infections of Guinea Pigs: Studies by Enzyme-Linked Immunosorbent Assay |
Search more.